Philip Yau

Mr. Yau has served on the board of directors at Legend Biotech since May 2020. He has over 23 years of experience in accounting, finance, mergers and acquisitions, investments, corporate finance audit, and risk management. Most recently, Mr. Yau served as the non-Executive Vice Chairman and Group Chief Financial Officer at AMTD Group where he led the strategy development, corporate finance and investment function. From September 2011 to March 2016, he worked at Ernst & Young China Practice as a partner and risk advisory China South market leader, serving clients in Greater China, where he advised on finance, management, and business issues. From January 2006 to July 2011, he worked at Protiviti Shanghai Co., Ltd. serving clients in Greater China, and as a managing director and Shenzhen office leader, where he was primarily responsible for overall management of the company. From 1997 to 2006, he worked at PricewaterhouseCoopers and Arthur Andersen & Co. in various roles with his most recent position as a senior manager in the risk consulting practice.

Mr. Yau is a certified public accountant in the United States, a fellow member of the Hong Kong Institute of Certified Public Accountants in China, and a certified internal auditor with the Institute of Internal Auditors.

Mr. Yau graduated from the Lundquist College of Business of University of Oregon in the United States with a Bachelor of Arts degree in Accounting in 1997. Mr. Yau obtained his Executive Master of Business Administration degree from a joint school program by the Kellogg School of Management, Northwestern University and the Hong Kong University of Science and Technology China in 2019.